Originally published byEU-Startups
Resurrect Bio, a London-based agricultural BioTech startup developing disease-resistant crops, has closed its oversubscribed Series A funding round at €8.8 million ($10.3 million). In February 2026, the company made an initial close of over €6.8 million ($8 million) in its Series A round. The round was led by Corteva through its Corteva Catalyst platform, with […]
The post UK AgriBioTech startup Resurrect Bio closes €8.8 million Series A to develop disease-resistant crops appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Even Claude agrees: hole in its sandbox was real and dangerous
1d ago
Intel's CEO reveals early hiring challenges as bankruptcy concerns deterred top talent
1d ago
OpenAI floats buy-before-your-try AI availability guarantee
1d ago
Beyond a sleek interface: The new wave of European fintech
17h ago
UK Typhoon jets fitted with bargain-bin drone busters for Middle East sorties
2d ago